biotech IPO

IPO initial public offering markets raise financing
Biotech

Inflammation biotech Evommune eyes IPO to fund dermatitis trials

Evommune has become the latest indicator that drug developers are once again tempted by the public markets.
James Waldron Oct 10, 2025 6:35am
3D Rendering futuristic robot technology development artificial intelligence

MapLight illuminates $262M IPO plans to fund Cobenfy competitor

Oct 7, 2025 6:30am
IPO initial public offering Wall Street

Big Pharma-backed MapLight plots IPO

Sep 22, 2025 1:57pm
Wall Street stock exchange finance shares share price Nasdaq

LB Pharma upsizes IPO in 1st biotech listing since February

Sep 11, 2025 4:09am
dollars money ocean dollar bill

LB Pharmaceuticals eyes $228M in IPO cash

Sep 8, 2025 3:16pm
Money frozen in ice

CNS biotech attempts to break the IPO ice

Aug 25, 2025 11:10am